Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study).
No Thumbnail Available
Identifiers
Date
2021-07-16
Authors
García de Guadiana-Romualdo, Luis
Morell-García, Daniel
Favaloro, Emmanuel J
Vílchez, Juan A
Bauça, Josep M
Alcaide Martín, María J
Gutiérrez Garcia, Irene
de la Hera Cagigal, Patricia
Egea-Caparrós, José Manuel
Pérez Sanmartín, Sonia
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Coagulopathy is a key feature of COVID-19 and D-dimer has been reported as a predictor of severity. However, because D-dimer test results vary considerably among assays, resolving harmonization issues is fundamental to translate findings into clinical practice. In this retrospective multicenter study (BIOCOVID study), we aimed to analyze the value of harmonized D-dimer levels upon admission for the prediction of in-hospital mortality in COVID-19 patients. All-cause in-hospital mortality was defined as endpoint. For harmonization of D-dimer levels, we designed a model based on the transformation of method-specific regression lines to a reference regression line. The ability of D-dimer for prediction of death was explored by receiver operating characteristic curves analysis and the association with the endpoint by Cox regression analysis. Study population included 2663 patients. In-hospital mortality rate was 14.3%. Harmonized D-dimer upon admission yielded an area under the curve of 0.66, with an optimal cut-off value of 0.945 mg/L FEU. Patients with harmonized D-dimer ≥ 0.945 mg/L FEU had a higher mortality rate (22.4% vs. 9.2%; p
Description
MeSH Terms
Biomarkers
COVID-19
Fibrin Fibrinogen Degradation Products
Humans
Prognosis
Registries
Retrospective Studies
Severity of Illness Index
Spain
COVID-19
Fibrin Fibrinogen Degradation Products
Humans
Prognosis
Registries
Retrospective Studies
Severity of Illness Index
Spain
DeCS Terms
CIE Terms
Keywords
COVID-19, D-dimer, Harmonization, Mortality, Prognosis